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In 2015, during the outbreak of Zika virus (ZIKV) in Brazil, 
we identified 3 cases of acute hearing loss after exanthematous 
illness. Serology yielded finding compatible with ZIKV as the 
cause of a confirmed (n = 1) and a probable (n = 2) flavivirus in-
fection, indicating an association between ZIKV infection and 
transient hearing loss.
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Zika virus (ZIKV) is an arbovirus (family Flaviviridae, genus 
Flavivirus) that has been reported in Africa and Asia. In March 
2015, ZIKV was first detected in Rio Grande do Norte, Brazil 
[1]. Since then, ZIKV has spread rapidly throughout northeast 
Brazil and autochthonous circulation has been documented in 
the United States [2, 3].
Most cases of ZIKV infection exhibit mild to moderate 
symptoms including exanthema, conjunctivitis, headache, 
fever, arthralgia, and myalgia. Additionally, an increased 
number of neurologic disorders have been reported in a tem-
poral relationship with the ZIKV infection epidemic in Brazil 
[4] and other countries [2]. Although hearing loss has been 
previously reported in 1 patient during ZIKV infection in 
Malaysia, hearing impairment was not confirmed by audio-
metric test [5].
Here we report 1 confirmed and 2 probable acute ZIKV cases 
based on clinical evaluation and serological exams with tran-
sient sensorineural hearing loss (SNHL) supported by time-
based audiometric exams, admitted between May and July 
2015, during the ZIKV outbreak in Bahia, Brazil [4]. This study 
was approved by the Hospital Santa Izabel (Bahia) institutional 
review board (number 484.908). Informed written consent was 
obtained from all participants.
Patient 1
On 29 July 2015, a 23-year-old man was admitted to the ear, nose, 
and throat emergency department (ENTED) at Santa Izabel 
Hospital, with a 2-day history of hearing impairment complain-
ing in the right ear, without tinnitus or dizziness, with normal 
otoscopic findings. Two weeks prior to admission, he experi-
enced fever and itching exanthema for 3 days; myalgia, asthenia, 
headache, and periarticular edema in wrists for 2 days; and mild 
arthralgia in the ankles and wrists for 15 days (Figure 1A). On 
31 July, when hearing complaints were resolved, a first audiom-
etry test was performed and detected a mild hearing loss in the 
right ear (Supplementary Figure 1). Immunoglobulin M (IgM) 
antibody capture enzyme-linked immunosorbent assay (MAC-
ELISA) of acute-phase sera collected on 29 July found anti-ZIKV 
IgM antibodies but not IgM antibodies for dengue virus (DENV) 
or other arboviruses. Plaque reduction neutralization titer 
(PRNT) evaluation of convalescent samples collected 7 months 
later demonstrated a 4-fold increase in neutralizing antibody 
titers to ZIKV in the absence of a titer increase to DENV2 when 
compared to acute-phase titers (Supplementary Figure 1).
Patient 2
On 30 May 2015, a 54-year-old woman was seen in an ENTED 
with moderate bilateral hearing loss and no abnormality in oto-
logic and otoneurologic examinations. Three days prior to the 
medical visit, she experienced itching exanthema (symptoms 
persisted for 3 days), mild arthralgia in both feet (13 days), 
dizziness (6 days), bilateral metallic tinnitus (21 days), periar-
ticular edema in hands and feet, retroocular pain, myalgia, and 
headache (14 days) (Figure 1B). A previous audiometry exami-
nation was performed in 2014, showing mild SNHL in right and 
left ear. A second audiometry examination was performed on 5 
June 2015, during acute symptoms for ZIKV, which revealed a 
bilateral mild to moderate hearing loss involving all frequen-
cies in the right and left ear. Audiometric examination was 
performed again on 10 July 2015, revealing complete recovery 
to prior hearing thresholds (Figure 1B). MAC-ELISA testing 
of acute-phase sera collected on July 3 found anti-ZIKV and 
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DENV IgM antibodies, but not antibodies to chikungunya virus 
or other arboviruses. PRNT testing of convalescent samples col-
lected 7 months later demonstrated an 8-fold increase in neu-
tralizing antibody titers for ZIKV and DENV2 compared with 
acute-phase titers (Supplementary Table 3).
Patient 3
On 7 July 2015, a 58-year-old woman was admitted to the 
ENTED with a 2-day history of intense bilateral hearing 
impairment and tinnitus similar to falling tap water. No abnor-
malities in vestibular exams were detected. Thirteen days 
prior to admission, the patient experienced itching exanthema 
for 5 days, retroocular pain, myalgia, headache, asthenia, 
dizziness, and arthralgia in both hands and wrists for 7 days. 
A previous audiometric exam, performed in 2012, revealed a 
moderate to severe mixed hearing loss (MHL) in the left ear, 
caused by a dry central membrane tympanic perforation in 
the left ear, and a mild SNHL in the right ear. On 7 July, a 
new audiometric test revealed a profound MHL in the left ear 
and a moderate SNHL in the right ear. Interestingly, hearing 
loss was more intense in lower pitches, making speech percep-
tion difficult. An audiometry performed on July 27 revealed 
a partial recovery of hearing thresholds as compared to the 
audiometric exam performed in 2012 (Figure 1C). MAC-
ELISA testing of acute-phase sera collected on July 16 found 
anti-ZIKV and DENV IgM antibodies, but not antibodies 
Figure 1. Clinical course and laboratory results and time-based audiometry examinations for Zika virus–infected patients 1–3 (A–C, respectively). For the audiometry 
examinations, the frequency in hertz of the test tones is shown on the horizontal axis and sound intensity in decibels is shown on the vertical axis. Red symbols indicate 
responses for the right ear (AD), and blue symbols indicate responses for the left ear (AS). The “X” and “O” symbols represent responses to air-conducted stimuli. The “■” 
symbols represent responses to air-conducted stimuli with masking. The “<” and “>” symbols represent responses to bone-conducted stimuli. The “[” and “]” symbols repre-
sent responses to bone-conducted stimuli with masking. Thresholds of ≤20 dB were considered normal. Abbreviations: CHIKV, Chikungunya virus; DENV, dengue virus; HAI, 
hemagglutination inhibition assays; IgM, immunoglobulin M; PRNT, plaque reduction neutralization titer; qPCR, polymerase chain reaction; ZIKV, Zika virus.
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to chikungunya virus or other arboviruses. PRNT results of 
convalescent samples collected 7 months later demonstrated a 
16-fold increase in neutralizing antibodies for ZIKV, but not 
for DENV2 (Supplementary Table 3).
DISCUSSION
Hearing loss has been sporadically reported during infection 
with flaviviruses, including West Nile virus [6, 7], DENV [8], 
and ZIKV [5]. A  previously published case report suggesting 
ZIKV infection in association with hearing loss symptoms was 
not accompanied by audiometric tests and lacked strong evi-
dence of the scenario [5]. Here we demonstrated that unilat-
eral or bilateral hearing loss, tinnitus, and dizziness may occur 
during or early after ZIKV infection in adults (2 probable cases 
and 1 confirmed case), supported by time-based audiometric 
exams. Transient otologic symptoms persisted for up to 28 days 
causing moderate to severe hearing disability and interfering 
with speech comprehension.
The 3 cases reported in this study occurred during the ZIKV 
outbreak in Bahia, Brazil [4], had compatible clinical symptoms 
for an acute ZIKV infection, and had anti-ZIKV IgM antibod-
ies detected in acute-phase sera. All patients tested negative 
for ZIKV by quantitative polymerase chain reaction (qPCR), 
probably because of the time frame between infection onset 
and sampling [2]. Patients 2 and 3 had anti-DENV IgM ELISA 
antibodies, although this may be possibly due to the serologic 
cross-reactivity between ZIKV and DENV [2]. Comparing sam-
ples from acute to convalescent phase, we observed that PRNT 
values for ZIKV increased for all patients (patient 1, 1:40 to 
1:160; patient 2, 1:40 to 1:320; patient 3, <1:40 to 1:320). While 
patients 1 and 3 did not demonstrate an anti-DENV2 titer 
increase in PRNT, we observed an 8-fold increase for patient 
2 (1:640 to 1:5120). MAC-ELISA findings therefore provide 
confirmatory evidence in patient 1 for an acute ZIKV infection 
and suggestive evidence for patient 3. Based on the sum of sero-
logic results and the lack of additional convalescent samples to 
perform PRNT and hemagglutination assay to the other flavi-
virus and DENV serotypes, we considered patient 2 as incon-
clusive. Despite the extensive distribution of DENV in several 
countries, including Brazil [2], there is only 1 published case 
of sudden SNHL related to DENV hemorrhagic fever [8]. In 
addition, this DENV study had important confounding factors 
associated with hearing impairment that could not be excluded 
from the analysis, such as systemic vascular leak syndrome and 
antipyretic drugs [9, 10], reducing the impact of DENV infec-
tion associated with hearing loss.
The mechanism of SNHL associated with acute virus infec-
tion involves damage of the inner ear or auditory nerve, by a 
direct viral effect or mediated by an autoimmune process as 
previously described [11, 12]. For patient 2, bilateral hear-
ing loss was totally recovered, whereas a partial recovery was 
detected for patient 3. This partial recovery for patient 3 might 
be explained due to a progression of her previous middle ear 
process. Nonetheless, she denied any acuteness of the inactive 
chronic otitis media during these 3 years.
In conclusion, this report of 3 cases indicates that transient 
hearing impairment may be a specific manifestation of acute 
ZIKV disease. A subsequent case-control study would be nec-
essary to demonstrate this causal relationship and elucidate the 
mechanisms leading to auditory dysfunction in this setting. 
Further investigation might also highlight other possible rare 
events such as permanent hearing loss, facilitating the possible 
recommendation of audiometry examinations in adults during 
ZIKV outbreaks.
Supplementary Data
Supplementary materials are available at Clinical Infectious Diseases online. 
Consisting of data provided by the author to benefit the reader, the posted 
materials are not copyedited and are the sole responsibility of the author, so 
questions or comments should be addressed to the author.
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